Leukocyte immunoglobulin-like receptor B1 and B4 (LILRB1 and LILRB4)

Written By Mollie Rotmensch

Churchill H. Leukocyte immunoglobulin-like receptor B1 and B4 (LILRB1 and LILRB4): Highly sensitive and specific markers of acute myeloid leukemia with monocytic differentiation. Cytometry B Clin. Cytom. 2020; doi: 10.1002/cyto.b.21952.

Mollie Rotmensch
Previous

Antagonistic anti-LILRB1 monoclonal antibody regulates antitumor functions of natural killer cells
Next

LILRB4-targeting antibody-drug conjugates for the treatment of acute myeloid leukemia